IDiyas

For the Inventor, By the Inventor

New York, NY, United States of America

James David Beard

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 9.8

ph-index = 11

Forward Citations = 469(Granted Patents)


Location History:

  • Farmingdale, NY (US) (2010)
  • New York, NY (US) (2011 - 2021)

Company Filing History:

goldMedal9 out of 172 
 
Intra-cellular Therapies, Inc.
 patents
silverMedal5 out of 118 
 
Osi Pharmaceuticals, Inc.
 patents

Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 12139490 - Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one (2024-11-12),
2. 11066407 - Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2021-07-20),
3. 10597395 - Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof (2020-03-24),
4. 10464938 - Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof (2019-11-05),
5. 10221176 - Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2019-03-05),
6. 9751883 - Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3',4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2017-09-05),
7. 9315504 - Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof (2016-04-19),
8. 8796455 - Fused bicyclic mTOR inhibitors (2014-08-05),
9. 8779139 - Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof (2014-07-15),
10. 8314111 - Fused bicyclic motor inhibitors (2012-11-20),
11. 8309722 - Substituted heterocycle gamma-carbolines synthesis (2012-11-13),
12. 7943767 - Fused bicyclic mTOR inhibitors (2011-05-17),
13. 7923555 - Fused bicyclic mTor inhibitors (2011-04-12),
14. 7700594 - Fused bicyclic mTOR inhibitors (2010-04-20),

Title: **James David Beard: A Pioneering Inventor in Pharmaceutical Innovations**

Introduction

James David Beard, based in New York, NY, is a distinguished inventor with a remarkable portfolio of 14 patents. His work primarily focuses on pharmaceutical innovations, notably in the preparation of complex chemical compounds that have significant therapeutic applications.

Latest Patents

Among his latest contributions to the field, Beard has developed a process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one. This invention entails methods for creating substituted heterocycle fused gamma-carbolines, along with useful intermediates and methods to produce these compounds. Additionally, he has innovated a preparation method for certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and their pharmaceutically acceptable salts.

Career Highlights

Beard has contributed significantly to the pharmaceutical industry through his work at notable companies. He has been associated with Intra-Cellular Therapies, Inc. and Osi Pharmaceuticals, Inc., where he has made substantial advancements in drug development and formulation.

Collaborations

His journey through the landscape of innovation has been marked by collaborations with talented individuals in the field. Noteworthy coworkers include John Charles Tomesch and Peng Li, with whom he has shared insights and expertise to drive forward innovative projects.

Conclusion

James David Beard stands out as an influential figure in the realm of pharmaceutical inventions. His extensive patent portfolio highlights his commitment to developing novel solutions that contribute to advancements in medical science. Through his innovative approaches, Beard continues to inspire future generations of inventors in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…